Kromek Group PLC Kromek radiation detectors used during NATO Summit

TIDMKMK

Kromek Group PLC

17 July 2018

17 July 2018

Kromek Group plc

("Kromek" or the "Company")

Kromek radiation detectors deployed by the Belgian Federal Police during President Trump's attendance at NATO Summit in Brussels

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security screening and nuclear markets, is pleased to announce that its D3S advanced radiation detection device was successfully deployed by Belgian Federal Police (Airport Unit) supported by the European Commission Counter Terrorism Unit of the Directorate General for Home Affairs during the July 2018 NATO Summit in Brussels.

The Belgian Federal Police deployed the Kromek D3S wearable RIID during security sweeps conducted before and during the visit of U.S. President Donald Trump and other EU and NATO Heads of State. It was used to detect potential radiological threats present in objects such as cargo, vehicles, buildings and other equipment.

Kromek has been informed that, as with its use during President Trump's visit to Brussels in May 2017, the D3S deployment was successful and the Company's radiation detection systems proved the value of such equipment for law enforcement during not only special events but also routine patrol operations.

The Belgian Federal Police (Airport Unit) has expressed its strong commitment to mitigate terrorist threats in line with the EU action plan, presented in October 2017, to counter attacks involving chemical, biological, radiological and nuclear (CBRN) substances.

Dr Arnab Basu, Chief Executive Officer of Kromek, said: "We are pleased to have been involved in the successful security operation during the recent NATO summit in Brussels. It is another real-world example of how government agencies are using our leading radiation detection technology to protect cities from all possible threats. We continue to engage closely with DARPA, the European Commission and national law enforcement agencies around the globe to deploy our D3S equipment in both high-risk events and routine police missions."

For further information, please contact:

 
 Kromek Group plc 
 Arnab Basu, CEO 
  Derek Bulmer, CFO                          [phone] 
 Cenkos Securities plc (Nominated Adviser 
  and Joint Broker) 
 Max Hartley (NOMAD) 
  Julian Morse (Sales)                       [phone] 
 Cantor Fitzgerald Europe (Joint Broker) 
 Philip Davies 
  Will Goode                                 [phone] 
 Luther Pendragon Ltd (PR) 
 Harry Chathli 
  Claire Norbury 
  Alexis Gore                                [phone] 
 

About Kromek Group plc

Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NRADBGDRUDBBGIL

(END) Dow Jones Newswires

July 17, 2018 02:00 ET (06:00 GMT)